| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d3d16ea8a165e9c14beba22c800cd1c6 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 |
| filingDate |
2020-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_753bec85f6fef60863d780618829ad6b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c615a15fc1bac705e497d65ea5f83d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5915e142e40b82f76e6491af9b086bb7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10cc7c00b690d5ad521d76198f51a1ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_155e7914585a9925cc1a52cfaef2e3aa |
| publicationDate |
2021-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021074365-A1 |
| titleOfInvention |
ESTROGEN-RELATED RECEPTOR ALPHA (ERRα) MODULATORS |
| abstract |
The present invention is directed to compounds according to Formula I and the pharmaceutically acceptable salts thereof. The compounds can be used as modulators of Estrogen-related Receptor alpha (ERRα) and have utility in the treatment of ERRα-mediated diseases or conditions. (I) |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023011456-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023165525-A1 |
| priorityDate |
2019-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |